Lenvima, 10 mg, (lenvatinib): analogues of the preparation. Where is cheaper to buy Lenvima?

Lenvima (Lenvatinib) - a drug used to combat differentiated thyroid cancer, immune to traditional therapy with radioactive iodine. The active substance of the preparation has an action blocking intracellular signals, due to which the development and division of cancer cells is suspended.

By results of researches, application of the named means promotes an increase in parameters of a survival rate without development of pathological processes.

Where can Lenvima buy cheaper

Despite the fact that the drug was developed not so long ago, it has already been recognized as one of the priority tools in the treatment of this pathology. But it can be difficult to acquire it to an ordinary patient. In Moscow, for example, Lenvima capsules start at 145,000 rubles. In this situation, the well-established site WWW.ONKO24.COM, offering generics of known anti-cancer drugs, can come to the rescue.

Speaking about generics, it should be emphasized that these funds are in no way inferior to branded ones, because they have the same formula. That is, the analog will be just as effective as the Lenvima drug itself. The price is much lower, since, by acquiring the right to issue, the company does not spend money on research and advertising.

Application Features

Treatment with the drug is carried out only under the supervision of a specialist. Capsules "Lenvima" take inside, once a day, without chewing and washing down with water. It is not necessary to match the intake of the drug with the time of eating.

Patients are usually prescribed 24 mg per day. But the doses are adjusted depending on the patient's condition. And in some cases, a temporary suspension of medication is required. The duration of treatment is determined by the clinical benefit of using the drug.

Contraindications to prescription of the drug

The drug "Lenvima" is not prescribed for patients with hepatic and renal insufficiency, pregnant, as well as nursing and children under 18 years old, as well as those with a predisposition to allergic reactions to the components of the drug.

Patients suffering from hypertension who underwent surgery or radiation therapy, suffering from bradyarrhythmia or congestive heart failure, and those over 75 years of age should be treated with caution in using Lenvim's drug.

Women who take this drug should be protected from pregnancy at least a month after treatment is stopped.

Side effects

The use of the drug "Lenvima" can lead to the following side effects:

• urinary tract infections;
• Inflammation of the mouth;
• Development of palmar-plantar syndrome;
• The appearance of edema;
• High fatigue;
• Asthenia;
• Thrombocytopenia;
• Decreased appetite;
• Hypocalcemia;
• Weight loss;
• Hypokalemia;
• Insomnia;
• headache;
• Increasing AD;
• Pain in the back.

Since the use of Lenvima capsules (lenvatinib) may cause dizziness and severe fatigue in the patients, they should be careful when working with moving mechanisms and while driving a vehicle.